CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit during Development Stage [Member]
Balance at Dec. 31, 2013	$ 10,601,651	$ 18,574	$ 31,099,691	$ (20,516,614)
Balance (in shares) at Dec. 31, 2013		18,574,334
Issuance of common shares for cash	14,002,162	5,834	13,996,328	0
Issuance of common shares for cash (in shares)		5,834,234
Issuance of common shares for services	0	23	(23)	0
Issuance of common shares for services (in shares)		22,731
Financing fees from 2014 Public Offering	(1,078,417)	0	(1,078,417)	0
Amortization of deferred financing costs	(225,000)	0	(225,000)	0
Issuance of Common shares upon exercise of warrants	32,000	20	31,980	0
Issuance of Common shares upon exercise of warrants (in shares)		20,000
Employees option exercise and cancellation of restricted stock grants	200,000	113	199,887	0
Employees option exercise and cancellation of restricted stock grants (in shares)		112,759
Compensation cost for stock options granted to executives and employees	545,115	0	545,115	0
Net loss for the nine months ended September 30, 2014	(8,844,902)	0	0	(8,844,902)
Balance at Sep. 30, 2014	$ 15,232,609	$ 24,564	$ 44,569,561	$ (29,361,516)
Balance (in shares) at Sep. 30, 2014		24,564,058